1.17
price down icon0.85%   -0.01
after-market Handel nachbörslich: 1.17
loading

Mindwalk Holdings Corp Aktie (HYFT) Neueste Nachrichten

pulisher
Mar 04, 2026

HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill

Mar 04, 2026
pulisher
Mar 04, 2026

HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 02, 2026

MindWalk Holdings to Report Q3 2026 Earnings - National Today

Mar 02, 2026
pulisher
Mar 02, 2026

MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net

Mar 02, 2026
pulisher
Mar 02, 2026

MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results - Stock Titan

Mar 02, 2026
pulisher
Feb 25, 2026

HYFT Technical Analysis & ETF Price Forecast - Intellectia AI

Feb 25, 2026
pulisher
Feb 18, 2026

Zacks Research Upgrades MindWalk (NASDAQ:HYFT) to Hold - MarketBeat

Feb 18, 2026
pulisher
Jan 27, 2026

Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire

Jan 27, 2026
pulisher
Jan 27, 2026

MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks

Jan 27, 2026
pulisher
Jan 27, 2026

MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance

Jan 27, 2026
pulisher
Jan 26, 2026

MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai

Jan 26, 2026
pulisher
Jan 22, 2026

HYFT Forecast — Price Prediction for 2026. Should I Buy HYFT? - Intellectia AI

Jan 22, 2026
pulisher
Jan 22, 2026

After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛

Jan 22, 2026
pulisher
Jan 15, 2026

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace

Jan 15, 2026
pulisher
Jan 14, 2026

Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com

Jan 14, 2026
pulisher
Jan 12, 2026

Scientists trace a hidden flu constraint across strains and hosts - Stock Titan

Jan 12, 2026
pulisher
Jan 12, 2026

REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance

Jan 12, 2026
pulisher
Jan 11, 2026

MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus

Jan 11, 2026
pulisher
Jan 10, 2026

MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com

Jan 10, 2026
pulisher
Jan 09, 2026

MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net

Jan 09, 2026
pulisher
Jan 09, 2026

MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com

Jan 09, 2026
pulisher
Jan 09, 2026

MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm

Jan 09, 2026
pulisher
Jan 06, 2026

MindWalk Holdings Corp. (HYFT) Competitors - Meyka

Jan 06, 2026
pulisher
Dec 29, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Sahm

Dec 29, 2025
pulisher
Dec 27, 2025

HYFT: MindWalk Holdings Corp.Balance Sheet - Zacks Investment Research

Dec 27, 2025
pulisher
Dec 18, 2025

MindWalk Holdings Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYFT) 2025-12-18 - Seeking Alpha

Dec 18, 2025
pulisher
Dec 17, 2025

MindWalk Holdings Corp. (HYFT) reports Q2 loss, lags revenue estimates - MSN

Dec 17, 2025
pulisher
Dec 16, 2025

MindWalk : Second Quarter 2026 Transcript - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

MindWalk reports 54% revenue growth in Q2 fiscal 2026 By Investing.com - Investing.com Australia

Dec 16, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp.Common Stock (NQ: HYFT - Markets Financial Content

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Dec 15, 2025
pulisher
Dec 15, 2025

HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView — Track All Markets

Dec 15, 2025
pulisher
Dec 15, 2025

Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth By Investing.com - Investing.com South Africa

Dec 15, 2025
pulisher
Dec 15, 2025

Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth - Investing.com

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline - Business Wire

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk reports 54% revenue growth in Q2 fiscal 2026 - Investing.com India

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings (HYFT) Reports Strong Revenue Growth Despite E - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Emphasizes AI-Driven Strategy in Latest Financial Release - TipRanks

Dec 15, 2025
pulisher
Dec 15, 2025

MindWalk Holdings Corp. (HYFT) provides Q2 MD&A and financials update - Stock Titan

Dec 15, 2025
pulisher
Dec 15, 2025

[6-K] MindWalk Holdings Corp. Current Report (Foreign Issuer) | HYFT SEC FilingForm 6-K - Stock Titan

Dec 15, 2025
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):